Nicole Lurie | Strategic Advisor To Chief Executive Officer

Nicole Lurie, Strategic Advisor To Chief Executive Officer, CEPI

Nicole Lurie, M.D., M.S.P.H. is currently Strategic Advisor to the Coalition for Epidemic Preparedness Initiatives (CEPI), and an advisor to the World Bank and the World Health Organization, and is appointed to the research faculty at Massachusetts General Hospital.  She recently completed an 8-year term as Assistant Secretary for Preparedness and Response at the US Department of Health and Human Services.  In that role she led the HHS response to numerous public health emergencies, ranging from infectious disease to natural and man-made disasters and is responsible for many innovations in emergency preparedness and response.  She also chaired the Public Health Emergency Medical Countermeasures Enterprise, a government wide organization ultimately responsible for the development of medical countermeasures, including vaccines against pandemics and emerging threats.  Prior to federal service, she was the Paul O'Neill Professor of Policy Analysis at RAND, where she started and led the public health preparedness program and RAND's Center for Population Health and Health Disparities.  She has also had leadership roles in academia, as Professor of Medicine and Public Health at the University of Minnesota, as Medical Advisor to the Commissioner, Minnesota Department of Health, and as Principal Deputy Assistant Secretary for Health at the US Department of Health and Human Services.  Dr. Lurie received her BA and MD degrees from the University of Pennsylvania, and completed her residency and public health training at UCLA.  Her research has focused on access to and quality of care, health system redesign, equity, mental health, public health and preparedness.  She is recipient of numerous awards and is a member of the National Academy of Medicine.  She continues to practice clinical medicine in a community clinic in Washington DC


April 15 Plenary Congress Day 1 @ 09:45

How can we be better prepared for disease X?

  • What kind of regulatory and political support can we expect?
  • Prevention and pre-prepared efforts to ensure our current and future safety
  • Vaccine development and innovation including the current landscape, existing challenges, and drivers and levers to incentivize development
last published: 11/Apr/19 16:05 GMT

back to speakers

Sign Up for Event Updates

Get Involved At World Vaccine Congress Washington


To Sponsor Or Exhibit

Marc Rhys-Evans
+44 20 7827 5945




To Register

Tayyab Abbasi
+44 20 7092 1210




Press Relations

Karina Kusova
+44 20 7092 1071